Resmed Inc reports results for the quarter ended in January - Earnings Summary

ResMed

02/08/2024 24:31

* Resmed Inc  RMD.N  reported quarterly adjusted earnings of
$2.08​​ per share for the quarter ended in January, higher than
the same quarter last year, when the company reported EPS of
$1.60.  The mean expectation of twelve analysts for the quarter
was for earnings of $2.07 per share. Wall Street expected
results to range from $1.95  to $2.18 per share.
    * Revenue rose 9% to $1.22 billion from a year ago; analysts
expected $1.22 billion. 
    * Resmed Inc's reported EPS for the quarter was $1.98​.
    * The company reported quarterly net income of $292.2
million.
    * Resmed Inc shares had risen by 11.4% this quarter and
gained 24.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 0.3%
in the last three months.​ 
    * In the last 30 days, two analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 7
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Resmed Inc is
$222.64 
This summary was machine generated from LSEG data August 1 at
11:30 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jan. 1 0001       2.07           2.08           Beat
 Mar. 31 2024      1.91           2.13           Beat
 Dec. 31 2023      1.80           1.88           Beat
 Sep. 30 2023      1.62           1.64           Beat